Skip to content

Impact of Olfactory Odour StimulatioN on Energy EXpenditure

SNEEX - Impact of Olfactory Odour StimulatioN on Energy EXpenditure

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05472168
Acronym
SNEEX
Enrollment
58
Registered
2022-07-25
Start date
2022-01-18
Completion date
2024-10-30
Last updated
2023-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

In this preliminary short-term study it is investigated, whether a short olfactory stimulation with distinct odours impacts energy expenditure in patients with obesity and lean patients.

Interventions

Participants are exposed to different odours and energy expenditure is assessed via indirect calorimetry.

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* • Age 18-55 years * Obesity (BMI ≥30 kg/m2) and Lean (BMI 18-25 kg/m2) * Written informed consent * Normosmia (defined by sniffing Sticks test)

Exclusion criteria

* • Chronic or acute sinusitis * Surgical intervention of the nasal cavity or the paranasal sinus * Known allergy to odors used in the study * Smokers * Current illicit drug abuse including daily marijuana and cannabidiol (CBD) consumption (alcohol ≤2 drinks per day allowed) * Any kind of severe chronic disease (e.g. severe heart failure, active cancer disease) * Diabetes mellitus * Treatment with insulin sensitizing drugs including Glucagon-like Peptide (GLP)-1 analogues within the last 3 months * History of neurodegenerative diseases, severe head trauma * Severe renal impairment (e.g. estimated glomerular filtration rate \<30 ml/min/m2) * Known liver cirrhosis or other severe liver impairment * Use of any kind of decongestant more than twice a week * Use of cortisone-containing nasal spray within the last 3 months * Acute upper respiratory tract infection * Uncontrolled dysthyroidism * Uncontrolled hypertension * Regular use of psychopharmaceutic drugs * Study participants aims to start a new diet or exercise program during the study * Bariatric surgery * Pregnancy/Lactation * Onset of climacteric symptoms within one year (e.g. hot flashes and/or diaphoresis) OR initiation of hormonal replacement therapy in the last three months * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. * Participation in an interventional study within the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Energy Expenditure6 hourschange in energy expenditure as assessed via calorimetry after olfactory stimulation with different odours.

Secondary

MeasureTime frameDescription
Energy Expenditure, Additional Odours6 hoursChange in energy expenditure as assessed via calorimetry after olfactory stimulation with Different odours
Heart Rate6 hourschange in heart rate variability upon olfactory stimulation with different odors as assessed via continuous ECG
Blood Pressure6 hoursChange in blood pressure upon olfactory stimulation with different odors as assessed via a blood pressure cuff at the upper arm according to Riva Rocci
Metabolic Parameters6 hoursChange in metabolic blood parameters upon acute olfactory stimulation with different odours
Glucose Levels6 hourschange in interstitial fluid glucose levels upon olfactory stimulation with different odours

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026